Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
992.7 USD | +0.55% | +0.75% | +12.95% |
May. 20 | Regeneron, Sanofi Disclose Positive Results for Lung Disease Treatment Candidate | MT |
May. 20 | Jefferies Raises Regeneron Pharmaceuticals' Price Target to $1,125 From $1,115 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.95% | 107B | |
+7.93% | 115B | |
-13.13% | 22.31B | |
-3.99% | 21.6B | |
-6.50% | 18.23B | |
-39.93% | 17.62B | |
+7.04% | 14.26B | |
+32.78% | 12.37B | |
-28.32% | 8.28B | |
+18.18% | 8.26B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2023, May-16-2023 09